logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Gabriel, Ian Howell
    Born in February 1974
    Individual (4 offsprings)
    Officer
    2017-05-09 ~ now
    OF - Director → CIF 0
    Mr Ian Howell Gabriel
    Born in February 1974
    Individual (4 offsprings)
    Person with significant control
    2017-05-09 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

GAYBRYL ONCOLOGY LTD

Period: 2017-05-09 ~ now
Company number: 10760716
Registered name
GAYBRYL ONCOLOGY LTD - now
Standard Industrial Classification
86220 - Specialists Medical Practice Activities
Brief company account
Property, Plant & Equipment
175 GBP2024-03-31
242 GBP2023-05-31
Debtors
7,037 GBP2024-03-31
35,591 GBP2023-05-31
Cash at bank and in hand
921,208 GBP2024-03-31
685,125 GBP2023-05-31
Current Assets
928,245 GBP2024-03-31
720,716 GBP2023-05-31
Creditors
Current
283,562 GBP2024-03-31
208,587 GBP2023-05-31
Net Current Assets/Liabilities
644,683 GBP2024-03-31
512,129 GBP2023-05-31
Total Assets Less Current Liabilities
644,858 GBP2024-03-31
512,371 GBP2023-05-31
Equity
Called up share capital
1 GBP2024-03-31
1 GBP2023-05-31
Retained earnings (accumulated losses)
644,857 GBP2024-03-31
512,370 GBP2023-05-31
Equity
644,858 GBP2024-03-31
512,371 GBP2023-05-31
Average Number of Employees
12023-06-01 ~ 2024-03-31
12022-06-01 ~ 2023-05-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
804 GBP2023-05-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
629 GBP2024-03-31
562 GBP2023-05-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
67 GBP2023-06-01 ~ 2024-03-31
Property, Plant & Equipment
Plant and equipment
175 GBP2024-03-31
242 GBP2023-05-31
Other Debtors
Amounts falling due within one year, Current
7,037 GBP2024-03-31
35,591 GBP2023-05-31
Trade Creditors/Trade Payables
Current
35,548 GBP2024-03-31
4,755 GBP2023-05-31
Other Taxation & Social Security Payable
Current
134,439 GBP2024-03-31
86,699 GBP2023-05-31
Other Creditors
Current
113,575 GBP2024-03-31
117,133 GBP2023-05-31

  • GAYBRYL ONCOLOGY LTD
    Info
    Registered number 10760716
    The Stables, 23b Lenten Street, Alton, Hampshire GU34 1HG
    PRIVATE LIMITED COMPANY incorporated on 2017-05-09 (8 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2025-05-08
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.